Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Cancer cells often have more copies of TERT and TERC genes, which helps them grow and could affect patient outcomes.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.

Keratin 79 marks a new group of cells that are key for creating and repairing the hair follicle's structure.

Male pattern hair loss caused by follicular miniaturization; early diagnosis and treatment can reduce psychological burden.

WNT10A helps esophageal cancer cells spread and keep renewing themselves.

Most patients with chronic hair shedding did not progress to permanent hair loss, and one showed improvement with treatment.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

Finasteride effectively improves hair growth and slows hair loss in men with male pattern baldness.

New treatments targeting skin stem cells show promise for skin repair, anti-aging, and cancer therapy.

Diagnose and manage CCCA with thorough history, exams, and labs; treat with anti-inflammatory agents, stress reduction, and stopping harmful hair practices.

Certain signals are important for reducing specific chemical markers on hair follicle stem cells during rest periods, which is necessary for healthy hair growth.

Gonadal hormones significantly affect the severity of alopecia areata in mice.

Valproic acid helps delay hair loss and increases survival time for high-grade glioma patients undergoing radiation therapy.

New method measures female hair loss: Female Pattern Hair Loss Severity Index (FPHL-SI).

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

The study concluded that severity of Frontal fibrosing alopecia is not linked to how long someone has it, can start before menopause, and eyebrow loss may be an early sign.

The document concludes that clinicians should be aware of common hair and scalp disorders in women of African descent and that more research is needed to develop effective treatments.

Proper education can prevent traction alopecia in women of color.

Early diagnosis and aggressive treatment are key for managing rare scalp disorders that cause permanent hair loss.

Non-invasive methods show promise for diagnosing skin diseases like psoriasis and lupus but need more research for regular use.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

ULBP3 could be a marker for diagnosing alopecia areata incognita and may be linked to its cause and development.

HIV patients with lower CD4 T cell counts often have more skin problems.

Some psychoactive drugs can cause skin reactions, with carbamazepine having a higher risk, and stopping the drug and seeing a dermatologist is important.

A Turkish family with sparse hair and eyebrow loss has a mutation in the U2HR gene linked to Marie Unna hereditary hypotrichosis.

New treatments for PCOS focus on managing symptoms and improving fertility.